Hydrochloric Acid

Hydrochloric Acid

SCHEMBL16666207

CCCCCCCCCCCCCCCCCC[N+]1(CCCCCCCCCCCCCCCCCC)CCCCC1.[Cl-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
THRB P10828 1/20 0.38
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38
GNAI1 P63096 1/20 0.38
DNM1 Q05193 5/20 0.32
LMNA P02545 3/20 0.31
ALDH1A1 P00352 2/20 0.31
KMT2A Q03164 2/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10335556 1.00 TSHR (0.38) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL9784558 1.00 TSHR (0.38) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL30212844 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL30212762 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL30213015 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL30212801 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL30213165 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL30212979 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL9784569 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL30212655 0.98 GNAI3 (0.37) TSHRTHRBGNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043636-B2 Method for producing triarylorganoborates COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2024-07-23 US disclosed
US-20240002409-A1 METHOD FOR PRODUCING TRIARYLORGANOBORATES COVESTRO DEUTSCHLAND AG (DE) 2024-01-04 US disclosed
US-11760765-B2 Method for producing triarylorganoborates COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2023-09-19 US disclosed
US-11078218-B2 Process for the production of triaryl organoborates COVESTRO DEUTSCHLAND AG (DE) 2021-08-03 US disclosed
US-20190276479-A1 PROCESS FOR THE PRODUCTION OF TRIARYL ORGANOBORATES COVESTRO DEUTSCHLAND AG (DE) 2019-09-12 US disclosed
US-20190263838-A1 METHOD FOR PRODUCING TRIARYLORGANOBORATES COVESTRO DEUTSCHLAND AG (DE) 2019-08-29 US disclosed
US-10001703-B2 Photopolymer formulation for production of holographic media comprising borates with low TG COVESTRO DEUTSCHLAND AG (DE) 2018-06-19 US disclosed
US-20160252808-A1 PHOTOPOLYMER FORMULATION FOR PRODUCTION OF HOLOGRAPHIC MEDIA COMPRISING BORATES WITH LOW TG COVESTRO DEUTCHLAND AG (DE) 2016-09-01 US disclosed
EP-3058423-A1 PHOTOPOLYMER FORMULATION FOR PRODUCTION OF HOLOGRAPHIC MEDIA COMPRISING BORATES WITH LOW TG Covestro Deutschland AG (DE) 2016-08-24 EP disclosed
WO-2015055576-A1 PHOTOPOLYMER FORMULATION FOR PRODUCTION OF HOLOGRAPHIC MEDIA COMPRISING BORATES WITH LOW TG BAYER MATERIALSCIENCE AG (DE) 2015-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002409-A1 METHOD FOR PRODUCING TRIARYLORGANOBORATES KMO, COASY, CYP3A4 TSHR 3184/4885THRB 1742/4885GNAI3 3199/4885
US-11078218-B2 Process for the production of triaryl organoborates OR10J3, CYP4F3, CYP4B1 TSHR 2354/4885THRB 430/4885GNAI3 2595/4885
US-12043636-B2 Method for producing triarylorganoborates KMO, COASY, CYP3A4 TSHR 3184/4885THRB 1742/4885GNAI3 3199/4885
US-20190263838-A1 METHOD FOR PRODUCING TRIARYLORGANOBORATES CYP3A4, CYP3A43, CYP4B1 TSHR 3341/4885THRB 1733/4885GNAI3 3506/4885
US-10001703-B2 Photopolymer formulation for production of holographic media comprising borates with low TG PTGIS, TST, MACF1 TSHR 4143/4885THRB 4523/4885GNAI3 788/4885
US-20160252808-A1 PHOTOPOLYMER FORMULATION FOR PRODUCTION OF HOLOGRAPHIC MEDIA COMPRISING BORATES WITH LOW TG PTGIS, TST, MACF1 TSHR 4143/4885THRB 4523/4885GNAI3 788/4885
US-11760765-B2 Method for producing triarylorganoborates CYP3A4, CYP3A43, CYP4B1 TSHR 3341/4885THRB 1733/4885GNAI3 3506/4885
US-20190276479-A1 PROCESS FOR THE PRODUCTION OF TRIARYL ORGANOBORATES CYP1B1, CYP3A4, CYP4B1 TSHR 3103/4885THRB 834/4885GNAI3 3172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.